Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions

Radiotherapy and Oncology

Volumn 99, Issue 2, 2011, Pages 166-171

  Stauder, Michael C ^a   MacDonald, O Kenneth ^a   Olivier, Kenneth R ^a   Call, Jason A ^a   Lafata, Kyle ^a   Mayo, Charles S ^a   Miller, Robert C ^a   Brown, Paul D ^a   Bauer, Heather J ^a   Garces, Yolanda I ^a  

^a MAYO CLINIC   (United States)

Author keywords

Lung neoplasms; Non small cell lung carcinoma; Radiation pneumonitis; Radiotherapy; Stereotactic body radiotherapy

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; CANCER SURGERY; CHEMORADIOTHERAPY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CONE-BEAM COMPUTED TOMOGRAPHY; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOSURGERY; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79958079919     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.04.002     Document Type: Article

References (37)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. C.F. Mountain A new international staging system for lung cancer Chest 89 1986 225S 233S (Pubitemid 16138265)
3. T. Naruke, T. Goya, R. Tsuchiya, and K. Suemasu Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
4. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795 (Pubitemid 44423123)
5. P. Fritz, H.J. Kraus, and W. Muhlnickel Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases Radiat Oncol 1 2006 30
6. R. Onimaru, H. Shirato, and S. Shimizu Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135 (Pubitemid 36403684)
7. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 100
8. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839 (Pubitemid 46630909)
9. J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller, and M. Flentje Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 60 2004 186 196 (Pubitemid 39165484)
10. T. Xia, H. Li, and Q. Sun Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 117 125 (Pubitemid 44175645)
11. Radiation Therapy Oncology Group. Lung Cancer Protocols. 0813 Phase I/II SBRT. http://www.rtog.org/members/protocols/0813/0813.pdf Accessed 15 Mar, 2010.
12. Radiation Therapy Oncology Group. Lung Cancer Protocols. 0618 Phase II SBRT. http://www.rtog.org/members/protocols/0618/0618.pdf Accessed 15 Mar, 2010.
13. Radiation Therapy Oncology Group. Lung Cancer Protocols. 0915 Phase II SBRT. http://www.rtog.org/members/protocols/0915/0915.pdf. Accessed 15 Mar, 2010.
14. O.K. Macdonald, J.J. Kruse, and J.M. Miller Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis Int J Radiat Oncol Biol Phys 75 2009 950 958
15. National Cancer Institute: Common Terminology Criteria for Adverse Events Version 3.0 2006 Bethesda MD
16. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
17. K.L. Stephans, T. Djemil, and C.A. Reddy Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients J Thorac Oncol 4 2009 838 844
18. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland clinic experience J Thorac Oncol 4 2009 976 982 doi: 910.1097/JTO.1090b1013e3181adf1509
19. G.M.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control Int J Radiat Oncol Biol Phys 77 2010 344 349
20. S.Y. Song, W. Choi, and S.S. Shin Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus Lung Cancer 66 2009 89 93
21. G.S. Sibley, T.A. Jamieson, L.B. Marks, M.S. Anscher, and L.R. Prosnitz Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience Int J Radiat Oncol Biol Phys 40 1998 149 154 (Pubitemid 28027580)
22. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective Phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
23. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective Phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
24. R.C. McGarry, L. Papiez, M. Williams, T. Whitford, and R.D. Timmerman Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015 (Pubitemid 41505277)
25. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a Phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431 (Pubitemid 41628038)
26. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA-J Am Med Assoc 303 2010 1070 1076
27. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for Stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
28. Dawood OMD. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife Radiosurgery for Operable Lung Cancer Patients. http://wwwaccuraycom/ PressReleasesaspx?release=676.
29. M. Uematsu, T. Fukui, K. Tahara, N. Sato, A. Shiota, and J. Wong Long-term results of computed tomography guided hypofractionated stereotactic radiotherapy for Stage I non-small cell lung cancers Int J Radiat Oncol Biol Phys 72 2008 S37
30. R.D. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients: analysis of RTOG 0236 Int J Radiat Oncol Biol Phys 75 2009 S3
31. M. Fujino, H. Shirato, and H. Onishi Characteristics of patients who developed radiation pneumonitis requiring steroid therapy after stereotactic irradiation for lung tumors Cancer J 12 2006 41 46
32. A. Takeda, T. Ohashi, and E. Kunieda Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after Stereotactic Body Radiotherapy (SBRT) in patients with lung tumors Int J Radiat Oncol Biol Phys 77 2010 685 690
33. H. Yamashita, K. Nakagawa, and N. Nakamura Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors Radiat Oncol 2 2007 21
34. G.R. Borst, M. Ishikawa, and J. Nijkamp Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy Radiother Oncol 91 2009 307 313
35. M. Guckenberger, K. Baier, and B. Polat Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy Radiother Oncol 97 2010 65 70
36. C.L. Ong, D. Palma, W.F.A.R. Verbakel, B.J. Slotman, and S. Senan Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity Radiother Oncol 97 2010 431 436
37. C. Robinson, K. Stephans, C. Reddy, T. Djemil, and G. Videtic Stereotactic Body Radiotherapy (SBRT) for radiographically diagnosed primary lung cancer without histologic confirmation Int J Radiat Oncol Biol Phys 75 2009 S453 S454